Abstract
The mechanisms by which neoplastic cells tolerate oncogene-induced DNA replication stress are poorly understood. Cyclin-dependent kinase 2 (CDK2) is a major mediator of oncogenic DNA replication stress. In this study, we show that CDK2-inducing stimuli (including Cyclin E overexpression, oncogenic RAS, and WEE1 inhibition) activate the DNA repair protein RAD18. CDK2-induced RAD18 activation required initiation of DNA synthesis and was repressed by p53. RAD18 and its effector, DNA polymerase κ (Polκ), sustained ongoing DNA synthesis in cells harboring elevated CDK2 activity. RAD18-deficient cells aberrantly accumulated single-stranded DNA (ssDNA) after CDK2 activation. In RAD18-depleted cells, the G2/M checkpoint was necessary to prevent mitotic entry with persistent ssDNA. Rad18-/- and Polκ-/- cells were highly sensitive to the WEE1 inhibitor MK-1775 (which simultaneously activates CDK2 and abrogates the G2/M checkpoint). Collectively, our results show that the RAD18-Polκ signaling axis allows tolerance of CDK2-mediated oncogenic stress and may allow neoplastic cells to breach tumorigenic barriers.
© 2017 Yang et al.
MeSH terms
-
A549 Cells
-
Animals
-
Cell Cycle Proteins / antagonists & inhibitors
-
Cell Cycle Proteins / genetics
-
Cell Cycle Proteins / metabolism
-
Cyclin-Dependent Kinase 2 / genetics
-
Cyclin-Dependent Kinase 2 / metabolism
-
DNA Breaks, Single-Stranded*
-
DNA, Neoplasm / biosynthesis*
-
DNA, Neoplasm / genetics
-
DNA-Binding Proteins / genetics
-
DNA-Binding Proteins / metabolism*
-
DNA-Directed DNA Polymerase / genetics
-
DNA-Directed DNA Polymerase / metabolism*
-
Drug Resistance, Neoplasm*
-
G2 Phase Cell Cycle Checkpoints / drug effects
-
G2 Phase Cell Cycle Checkpoints / genetics
-
Humans
-
M Phase Cell Cycle Checkpoints / drug effects
-
M Phase Cell Cycle Checkpoints / genetics
-
Mice
-
Neoplasms / drug therapy
-
Neoplasms / genetics
-
Neoplasms / metabolism*
-
Nuclear Proteins / antagonists & inhibitors
-
Nuclear Proteins / genetics
-
Nuclear Proteins / metabolism
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Protein-Tyrosine Kinases / genetics
-
Protein-Tyrosine Kinases / metabolism
-
Pyrazoles / pharmacology
-
Pyrimidines / pharmacology
-
Pyrimidinones
-
Signal Transduction*
-
Tumor Suppressor Protein p53 / genetics
-
Tumor Suppressor Protein p53 / metabolism
-
Ubiquitin-Protein Ligases / genetics
-
Ubiquitin-Protein Ligases / metabolism*
Substances
-
Cell Cycle Proteins
-
DNA, Neoplasm
-
DNA-Binding Proteins
-
Nuclear Proteins
-
Pyrazoles
-
Pyrimidines
-
Pyrimidinones
-
RAD18 protein, human
-
TP53 protein, human
-
Tumor Suppressor Protein p53
-
Ubiquitin-Protein Ligases
-
Protein-Tyrosine Kinases
-
WEE1 protein, human
-
CDK2 protein, human
-
Cyclin-Dependent Kinase 2
-
DNA-Directed DNA Polymerase
-
POLK protein, human
-
adavosertib